Logo image of CRWD

CROWDSTRIKE HOLDINGS INC - A (CRWD) Stock Fundamental Analysis

USA - NASDAQ:CRWD - US22788C1053 - Common Stock

484.65 USD
+2.42 (+0.5%)
Last: 10/17/2025, 8:04:21 PM
484.5 USD
-0.15 (-0.03%)
After Hours: 10/17/2025, 8:04:21 PM
Fundamental Rating

4

CRWD gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 283 industry peers in the Software industry. The financial health of CRWD is average, but there are quite some concerns on its profitability. CRWD is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

CRWD had positive earnings in the past year.
CRWD had a positive operating cash flow in the past year.
In the past 5 years CRWD reported 4 times negative net income.
CRWD had a positive operating cash flow in each of the past 5 years.
CRWD Yearly Net Income VS EBIT VS OCF VS FCFCRWD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B

1.2 Ratios

CRWD's Return On Assets of -3.20% is in line compared to the rest of the industry. CRWD outperforms 49.29% of its industry peers.
CRWD has a Return On Equity (-7.91%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -3.2%
ROE -7.91%
ROIC N/A
ROA(3y)-0.84%
ROA(5y)-2.48%
ROE(3y)-3.08%
ROE(5y)-8.55%
ROIC(3y)N/A
ROIC(5y)N/A
CRWD Yearly ROA, ROE, ROICCRWD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -1K -2K -3K

1.3 Margins

The Gross Margin of CRWD (74.16%) is better than 63.48% of its industry peers.
CRWD's Gross Margin has been stable in the last couple of years.
CRWD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 74.16%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.6%
GM growth 5Y1.2%
CRWD Yearly Profit, Operating, Gross MarginsCRWD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150 -200

6

2. Health

2.1 Basic Checks

CRWD does not have a ROIC to compare to the WACC, probably because it is not profitable.
CRWD has more shares outstanding than it did 1 year ago.
The number of shares outstanding for CRWD has been increased compared to 5 years ago.
CRWD has a better debt/assets ratio than last year.
CRWD Yearly Shares OutstandingCRWD Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
CRWD Yearly Total Debt VS Total AssetsCRWD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

CRWD has an Altman-Z score of 13.69. This indicates that CRWD is financially healthy and has little risk of bankruptcy at the moment.
CRWD has a Altman-Z score of 13.69. This is amongst the best in the industry. CRWD outperforms 89.72% of its industry peers.
The Debt to FCF ratio of CRWD is 0.72, which is an excellent value as it means it would take CRWD, only 0.72 years of fcf income to pay off all of its debts.
CRWD's Debt to FCF ratio of 0.72 is fine compared to the rest of the industry. CRWD outperforms 76.60% of its industry peers.
A Debt/Equity ratio of 0.20 indicates that CRWD is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.20, CRWD perfoms like the industry average, outperforming 46.45% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 0.72
Altman-Z 13.69
ROIC/WACCN/A
WACC11.2%
CRWD Yearly LT Debt VS Equity VS FCFCRWD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

2.3 Liquidity

A Current Ratio of 1.88 indicates that CRWD should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.88, CRWD is in line with its industry, outperforming 58.87% of the companies in the same industry.
A Quick Ratio of 1.88 indicates that CRWD should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.88, CRWD is in line with its industry, outperforming 59.22% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.88
Quick Ratio 1.88
CRWD Yearly Current Assets VS Current LiabilitesCRWD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

8

3. Growth

3.1 Past

The earnings per share for CRWD have decreased by -3.21% in the last year.
Measured over the past years, CRWD shows a very strong growth in Earnings Per Share. The EPS has been growing by 79.46% on average per year.
The Revenue has grown by 23.46% in the past year. This is a very strong growth!
CRWD shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 52.37% yearly.
EPS 1Y (TTM)-3.21%
EPS 3Y79.46%
EPS 5YN/A
EPS Q2Q%-10.58%
Revenue 1Y (TTM)23.46%
Revenue growth 3Y39.65%
Revenue growth 5Y52.37%
Sales Q2Q%21.28%

3.2 Future

The Earnings Per Share is expected to grow by 22.11% on average over the next years. This is a very strong growth
CRWD is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 21.83% yearly.
EPS Next Y-4.67%
EPS Next 2Y11.32%
EPS Next 3Y17.41%
EPS Next 5Y22.11%
Revenue Next Year21.76%
Revenue Next 2Y21.82%
Revenue Next 3Y21.87%
Revenue Next 5Y21.83%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
CRWD Yearly Revenue VS EstimatesCRWD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 5B 10B 15B
CRWD Yearly EPS VS EstimatesCRWD Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 5 10 15 20

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 133.88, the valuation of CRWD can be described as expensive.
CRWD's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of CRWD to the average of the S&P500 Index (27.40), we can say CRWD is valued expensively.
Based on the Price/Forward Earnings ratio of 99.52, the valuation of CRWD can be described as expensive.
60.64% of the companies in the same industry are cheaper than CRWD, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.94. CRWD is valued rather expensively when compared to this.
Industry RankSector Rank
PE 133.88
Fwd PE 99.52
CRWD Price Earnings VS Forward Price EarningsCRWD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of CRWD is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 117.18
EV/EBITDA N/A
CRWD Per share dataCRWD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

CRWD's earnings are expected to grow with 17.41% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y11.32%
EPS Next 3Y17.41%

0

5. Dividend

5.1 Amount

No dividends for CRWD!.
Industry RankSector Rank
Dividend Yield N/A

CROWDSTRIKE HOLDINGS INC - A

NASDAQ:CRWD (10/17/2025, 8:04:21 PM)

After market: 484.5 -0.15 (-0.03%)

484.65

+2.42 (+0.5%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-27 2025-08-27/amc
Earnings (Next)11-24 2025-11-24/amc
Inst Owners73.69%
Inst Owner Change0.08%
Ins Owners3.03%
Ins Owner Change-1.5%
Market Cap121.63B
Analysts76.33
Price Target492.7 (1.66%)
Short Float %2.64%
Short Ratio2.01
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.62%
Min EPS beat(2)9.3%
Max EPS beat(2)9.95%
EPS beat(4)4
Avg EPS beat(4)12.71%
Min EPS beat(4)9.3%
Max EPS beat(4)18.62%
EPS beat(8)8
Avg EPS beat(8)9.93%
EPS beat(12)12
Avg EPS beat(12)12.73%
EPS beat(16)16
Avg EPS beat(16)20.56%
Revenue beat(2)0
Avg Revenue beat(2)-1.13%
Min Revenue beat(2)-2%
Max Revenue beat(2)-0.26%
Revenue beat(4)2
Avg Revenue beat(4)-0.23%
Min Revenue beat(4)-2%
Max Revenue beat(4)0.82%
Revenue beat(8)2
Avg Revenue beat(8)-0.57%
Revenue beat(12)3
Avg Revenue beat(12)-0.49%
Revenue beat(16)7
Avg Revenue beat(16)0.28%
PT rev (1m)5.19%
PT rev (3m)3.84%
EPS NQ rev (1m)0.09%
EPS NQ rev (3m)3.43%
EPS NY rev (1m)4.43%
EPS NY rev (3m)4.53%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.96%
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)0.04%
Valuation
Industry RankSector Rank
PE 133.88
Fwd PE 99.52
P/S 28.02
P/FCF 117.18
P/OCF 87.58
P/B 32.38
P/tB 44.63
EV/EBITDA N/A
EPS(TTM)3.62
EY0.75%
EPS(NY)4.87
Fwd EY1%
FCF(TTM)4.14
FCFY0.85%
OCF(TTM)5.53
OCFY1.14%
SpS17.3
BVpS14.97
TBVpS10.86
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.2%
ROE -7.91%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 74.16%
FCFM 23.91%
ROA(3y)-0.84%
ROA(5y)-2.48%
ROE(3y)-3.08%
ROE(5y)-8.55%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.6%
GM growth 5Y1.2%
F-Score3
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 0.72
Debt/EBITDA N/A
Cap/Depr 143.34%
Cap/Sales 8.08%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.88
Quick Ratio 1.88
Altman-Z 13.69
F-Score3
WACC11.2%
ROIC/WACCN/A
Cap/Depr(3y)197.98%
Cap/Depr(5y)189.45%
Cap/Sales(3y)9.2%
Cap/Sales(5y)8.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3.21%
EPS 3Y79.46%
EPS 5YN/A
EPS Q2Q%-10.58%
EPS Next Y-4.67%
EPS Next 2Y11.32%
EPS Next 3Y17.41%
EPS Next 5Y22.11%
Revenue 1Y (TTM)23.46%
Revenue growth 3Y39.65%
Revenue growth 5Y52.37%
Sales Q2Q%21.28%
Revenue Next Year21.76%
Revenue Next 2Y21.82%
Revenue Next 3Y21.87%
Revenue Next 5Y21.83%
EBIT growth 1Y-638.13%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year54.6%
EBIT Next 3Y38.46%
EBIT Next 5Y36.81%
FCF growth 1Y29.99%
FCF growth 3Y34.28%
FCF growth 5Y143.57%
OCF growth 1Y30.79%
OCF growth 3Y33.96%
OCF growth 5Y69.1%